Elevated homocysteine levels in blood are associated with increased risk of heart attack and stroke. Vitamin supplementation, particularly folic acid, may lower homocysteine levels and reduce cardiovascular disease risk.
Recent studies indicate that genetic variants, such as apoE4 and LDL subclass pattern B, can significantly impact an individual's cholesterol response to a low-fat diet. Individuals with these genetic predispositions may require specific dietary modifications to effectively manage their cholesterol levels and heart disease risk.
Recent research highlights the strong influence of genes on individual variations in response to diet, influencing predisposition to obesity and atherosclerosis. Genetic analysis may lead to tailored diet plans and drug regimens for heart disease and stroke prevention.
PhD scientist Ellen Heber-Katz presents groundbreaking findings on regenerative biology, using a mouse model to study epimorphic regeneration in humans. Her research may lead to treatments for organ replacement, chronic wounds, and spinal cord injuries.
Researchers at Duke University Medical Center have developed a groundbreaking treatment for Pompe disease, a rare genetic muscle-wasting disorder. The injectable enzyme therapy has shown promise in improving muscle strength and reducing glycogen buildup in muscles, offering new hope for children born with the fatal condition.
Researchers have created mouse models with induced mutant lipoproteins to study atherosclerosis, providing insights into the genes responsible for human diseases. The study reveals that breeding prone traits onto different strains has helped identify differences in susceptibility and resistance genes.
The study used identical twins to investigate the role of genes in individual differences in response to chronic overfeeding. The results showed significant similarity within pairs for body weight, fat distribution, and insulin levels, but reduced similarity when accounting for total body fat.